Halmos B - Search Results

1

Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Koschmieder S, Halmos B, Levantini E, Tenen DG. Koschmieder S, et al. Among authors: halmos b. J Clin Oncol. 2009 Feb 1;27(4):619-28. doi: 10.1200/JCO.2008.17.9812. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075268 Free PMC article. Review.

2

Down-regulation and antiproliferative role of C/EBPalpha in lung cancer.

Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. Halmos B, et al. Cancer Res. 2002 Jan 15;62(2):528-34. Cancer Res. 2002. PMID: 11809705

3

A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer.

Halmos B, Bassères DS, Monti S, D'Aló F, Dayaram T, Ferenczi K, Wouters BJ, Huettner CS, Golub TR, Tenen DG. Halmos B, et al. Cancer Res. 2004 Jun 15;64(12):4137-47. doi: 10.1158/0008-5472.CAN-03-4052. Cancer Res. 2004. PMID: 15205324

4

Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer.

Cho D, Kocher O, Lee JC, Tenen DG, Meyerson ML, Janne PA, Halmos B. Cho D, et al. Among authors: halmos b. J Clin Oncol. 2005 Jan 1;23(1):235-7. doi: 10.1200/JCO.2005.07.169. J Clin Oncol. 2005. PMID: 15625379 No abstract available.

5

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Kobayashi S, Boggon TJ, Dayaram T, Jänne PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG, Halmos B. Kobayashi S, et al. Among authors: halmos b. N Engl J Med. 2005 Feb 24;352(8):786-92. doi: 10.1056/NEJMoa044238. N Engl J Med. 2005. PMID: 15728811 Free article.

6

An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor.

Kobayashi S, Ji H, Yuza Y, Meyerson M, Wong KK, Tenen DG, Halmos B. Kobayashi S, et al. Among authors: halmos b. Cancer Res. 2005 Aug 15;65(16):7096-101. doi: 10.1158/0008-5472.CAN-05-1346. Cancer Res. 2005. PMID: 16103058

7

Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.

Mukohara T, Engelman JA, Hanna NH, Yeap BY, Kobayashi S, Lindeman N, Halmos B, Pearlberg J, Tsuchihashi Z, Cantley LC, Tenen DG, Johnson BE, Jänne PA. Mukohara T, et al. Among authors: halmos b. J Natl Cancer Inst. 2005 Aug 17;97(16):1185-94. doi: 10.1093/jnci/dji238. J Natl Cancer Inst. 2005. PMID: 16106023

8

Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in mice.

Bassères DS, Levantini E, Ji H, Monti S, Elf S, Dayaram T, Fenyus M, Kocher O, Golub T, Wong KK, Halmos B, Tenen DG. Bassères DS, et al. Among authors: halmos b. Mol Cell Biol. 2006 Feb;26(3):1109-23. doi: 10.1128/MCB.26.3.1109-1123.2006. Mol Cell Biol. 2006. PMID: 16428462 Free PMC article.

9

C/EBP alpha mutations in lung cancer.

Costa DB, Dayaram T, D'Alo F, Wouters BJ, Tenen DG, Meyerson M, Tsao MS, Halmos B. Costa DB, et al. Among authors: halmos b. Lung Cancer. 2006 Aug;53(2):253-4. doi: 10.1016/j.lungcan.2006.04.011. Epub 2006 Jun 12. Lung Cancer. 2006. PMID: 16765476 No abstract available.

10

Three-dimensional magnetic resonance microscopy of pulmonary solitary tumors in transgenic mice.

Kubo S, Levantini E, Kobayashi S, Kocher O, Halmos B, Tenen DG, Takahashi M. Kubo S, et al. Among authors: halmos b. Magn Reson Med. 2006 Sep;56(3):698-703. doi: 10.1002/mrm.21006. Magn Reson Med. 2006. PMID: 16902979 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page